- Home
- EXEL vs TER Comparison
EXEL vs TER Comparison
Compare EXEL & TER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- TER
- Stock Information
- Founded
- EXEL 1994
- TER 1960
- Country
- EXEL United States
- TER United States
- Employees
- EXEL N/A
- TER N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- TER Electrical Products
- Sector
- EXEL Health Care
- TER Industrials
- Exchange
- EXEL Nasdaq
- TER Nasdaq
- Market Cap
- EXEL 12.0B
- TER 13.9B
- IPO Year
- EXEL 2000
- TER N/A
- Fundamental
- Price
- EXEL $45.40
- TER $93.03
- Analyst Decision
- EXEL Buy
- TER Hold
- Analyst Count
- EXEL 18
- TER 15
- Target Price
- EXEL $44.29
- TER $112.86
- AVG Volume (30 Days)
- EXEL 2.7M
- TER 3.3M
- Earning Date
- EXEL 07-28-2025
- TER 07-29-2025
- Dividend Yield
- EXEL N/A
- TER 0.52%
- EPS Growth
- EXEL 237.58
- TER 33.94
- EPS
- EXEL 2.20
- TER 3.53
- Revenue
- EXEL $2,298,922,000.00
- TER $2,905,741,000.00
- Revenue This Year
- EXEL $9.93
- TER $3.91
- Revenue Next Year
- EXEL $13.17
- TER $18.50
- P/E Ratio
- EXEL $20.60
- TER $26.36
- Revenue Growth
- EXEL 24.49
- TER 9.30
- 52 Week Low
- EXEL $22.20
- TER $65.77
- 52 Week High
- EXEL $49.62
- TER $154.14
- Technical
- Relative Strength Index (RSI)
- EXEL 57.52
- TER 54.47
- Support Level
- EXEL $43.86
- TER $88.60
- Resistance Level
- EXEL $45.52
- TER $97.25
- Average True Range (ATR)
- EXEL 1.44
- TER 3.20
- MACD
- EXEL -0.07
- TER -0.43
- Stochastic Oscillator
- EXEL 39.60
- TER 41.71
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About TER Teradyne Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.